Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Mar;19(3):992–998. doi: 10.1128/iai.19.3.992-998.1978

Biochemical examination of sera during systemic Candida infection in mice.

D Oblack, J Schwarz, I A Holder
PMCID: PMC422289  PMID: 346492

Abstract

Candida pathogenesis was examined by intravenous challenge of mice with either C. albicans or C. guilliermondii. Animals were moribund 12 h postchallenge with C. albicans and were found to have the greatest number of organisms in the heart and kidney, severe interstitial myocarditis, and elevated serum levels of blood urea nitrogen, creatine phosphokinase, serum glutamic oxalacetic transaminase, serum glutamic pyruvic transaminase, and lactic dehydrogenase. In contrast, challenge with C. guilliermondii resulted in a significantly lower renal census, no myocarditis, and no significant change in the concentration of these serum constituents. Challenge with nonviable C. albicans did not produce the effects observed with viable organisms. Moreover, challenge with filamentous C. albicans resulted in biochemical alterations of lower magnitude and in lower mortality rates. These results indicated that altered serum biochemistries were correlated with the histopathology of fatal Candida infection and that there were distinct differences with C. guilliermondii and the dimorphic phases of C. albicans.

Full text

PDF
992

Images in this article

996Image
on p.996

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADRIANO S. M., SCHWARZ J. Experimental moniliasis in mice. Am J Pathol. 1955 Sep-Oct;31(5):859–873. [PMC free article] [PubMed] [Google Scholar]
  2. BAKER R. D. Leukopenia and therapy in leukemia as factors predisposing to fatal mycoses. Mucormycosis, aspergillosis, and cryptococcosis. Am J Clin Pathol. 1962 Apr;37:358–373. doi: 10.1093/ajcp/37.4.358. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P. Fungal infections complicating acute leukemia. J Chronic Dis. 1966 Jun;19(6):667–687. doi: 10.1016/0021-9681(66)90066-x. [DOI] [PubMed] [Google Scholar]
  4. CHITALE A. R., BHENDE Y. M. EXPERIMENTAL MONILIASIS IN RABBITS AND MICE. Indian J Pathol Bacteriol. 1965 Apr;39:89–97. [PubMed] [Google Scholar]
  5. Cannon P. J. The kidney in heart failure. N Engl J Med. 1977 Jan 6;296(1):26–32. doi: 10.1056/NEJM197701062960108. [DOI] [PubMed] [Google Scholar]
  6. Chilgren R. A., Hong R., Quie P. G. Human serum interactions with Candida albicans. J Immunol. 1968 Jul;101(1):128–132. [PubMed] [Google Scholar]
  7. Crocker C. L. Rapid determination of urea nitrogen in serum or plasma without deproteinization. Am J Med Technol. 1967 Sep-Oct;33(5):361–365. [PubMed] [Google Scholar]
  8. Evans Z. A., Mardon D. N. Organ localization in mice challenged with a typical Candida albicans strain and a pseudohyphal variant. Proc Soc Exp Biol Med. 1977 Jun;155(2):234–238. doi: 10.3181/00379727-155-39780. [DOI] [PubMed] [Google Scholar]
  9. GOLDSTEIN E., GRIECO M. H., FINKEL G., LOURIA D. B. STUDIES ON THE PATHOGENESIS OF EXPERIMENTAL CANDIDA PARAPSILOSIS AND CANDIDA GUILLIERMONDII INFECTIONS IN MICE. J Infect Dis. 1965 Jun;115:293–302. doi: 10.1093/infdis/115.3.293. [DOI] [PubMed] [Google Scholar]
  10. GROCOTT R. G. A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic. Am J Clin Pathol. 1955 Aug;25(8):975–979. doi: 10.1093/ajcp/25.8_ts.0975. [DOI] [PubMed] [Google Scholar]
  11. HASENCLEVER H. F. Comparative pathogenicity of Candida albicans for mice and rabbits. J Bacteriol. 1959 Jul;78(1):105–109. doi: 10.1128/jb.78.1.105-109.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HASENCLEVER H. F., MITCHELL W. O. Pathogenicity of C. albicans and C. tropicalis. Sabouraudia. 1961 Jan;1:16–21. [PubMed] [Google Scholar]
  13. HURLEY R. ACUTE DISSEMINATED (SEPTICAEMIC) MONILIASIS IN ADULTS AND CHILDREN. Postgrad Med J. 1964 Nov;40:644–653. doi: 10.1136/pgmj.40.469.644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HURLEY R., WINNER H. I. Experimental renal moniliasis in the mouse. J Pathol Bacteriol. 1963 Jul;86:75–82. doi: 10.1002/path.1700860109. [DOI] [PubMed] [Google Scholar]
  15. Hart P. D., Russell E., Jr, Remington J. S. The compromised host and infection. II. Deep fungal infection. J Infect Dis. 1969 Aug;120(2):169–191. doi: 10.1093/infdis/120.2.169. [DOI] [PubMed] [Google Scholar]
  16. Hess J. W., Murdock K. J., Natho G. J. Creatine phosphokinase. A spectrophotometric method with improved sensitivity. Am J Clin Pathol. 1968 Jul;50(1):89–97. doi: 10.1093/ajcp/50.1.89. [DOI] [PubMed] [Google Scholar]
  17. ISENBERG H. D., ALLERHAND J., BERKMAN J. I., GOLDBERG D. IMMUNOLOGICAL AND TOXIC DIFFERENCES BETWEEN MOUSE-VIRULENT AND MOUSE-AVIRULENT CANDIDA ALBICANS. J Bacteriol. 1963 Nov;86:1010–1018. doi: 10.21236/ad0435722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KEMP G., SOLOTOROVSKY M. Fluorescent antibody studies of pathogenesis in experimental Candida albicans infections of mice. J Immunol. 1962 Jun;88:777–781. [PubMed] [Google Scholar]
  19. Law E. J., Kim O. J., Stieritz D. D., MacMillan B. G. Experience with systemic candidiasis in the burned patient. J Trauma. 1972 Jul;12(7):543–552. doi: 10.1097/00005373-197207000-00001. [DOI] [PubMed] [Google Scholar]
  20. Louria D. B., Smith J. K., Brayton R. G., Buse M. Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations. J Infect Dis. 1972 Feb;125(2):102–114. doi: 10.1093/infdis/125.2.102. [DOI] [PubMed] [Google Scholar]
  21. MANKOWSKI Z. T. The experimental pathogenicity of various species of Candida in Swiss mice. Trans N Y Acad Sci. 1957 Apr;19(6):548–570. doi: 10.1111/j.2164-0947.1957.tb00549.x. [DOI] [PubMed] [Google Scholar]
  22. MOURAD S., FRIEDMAN L. Pathogenicity of Candida. J Bacteriol. 1961 Apr;81:550–556. doi: 10.1128/jb.81.4.550-556.1961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mardon D. N., Gunn J. L., Robinette E., Jr Variation in the lethal response in mice to yeast-like and pseudohyphal forms of Candida albicans. Can J Microbiol. 1975 Nov;21(11):1681–1687. doi: 10.1139/m75-246. [DOI] [PubMed] [Google Scholar]
  24. Marra S., Balish E. Immunity to Candida albicans induced by Listeria monocytogenes. Infect Immun. 1974 Jul;10(1):72–82. doi: 10.1128/iai.10.1.72-82.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. OLIVER I. T. A spectrophotometric method for the determination of creatine phosphokinase and myokinase. Biochem J. 1955 Sep;61(1):116–122. doi: 10.1042/bj0610116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Parker J. C., Jr, McCloskey J. J., Knauer K. A. Pathobiologic features of human candidiasis. A common deep mycosis of the brain, heart and kidney in the altered host. Am J Clin Pathol. 1976 Jun;65(6):991–1000. doi: 10.1093/ajcp/65.6.991. [DOI] [PubMed] [Google Scholar]
  27. Rifkind D., Marchioro T. L., Schneck S. A., Hill R. B., Jr Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features. Am J Med. 1967 Jul;43(1):28–38. doi: 10.1016/0002-9343(67)90146-5. [DOI] [PubMed] [Google Scholar]
  28. Roberts R., Sobel B. E. Elevated plasma MB creatine phosphokinase activity. A specific marker for myocardial infarction in perioperative patients. Arch Intern Med. 1976 Apr;136(4):421–424. [PubMed] [Google Scholar]
  29. Rogers T., Balish E. Experimental Candida albicans infection in conventional mice and germfree rats. Infect Immun. 1976 Jul;14(1):33–38. doi: 10.1128/iai.14.1.33-38.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rosalki S. B. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med. 1967 Apr;69(4):696–705. [PubMed] [Google Scholar]
  31. Rose H. D., Varkey B. Deep mycotic infection in the hospitalized adult: a study of 123 patients. Medicine (Baltimore) 1975 Nov;54(6):499–507. doi: 10.1097/00005792-197511000-00004. [DOI] [PubMed] [Google Scholar]
  32. SALVIN S. B. Endotoxin in pathogenic q fungi. J Immunol. 1952 Jul;69(1):89–99. [PubMed] [Google Scholar]
  33. Saymen D. G., Nathan P., Holder I. A., Hill E. O., Macmillan B. G. Infected surface wound: an experimental model and a method for the quantitation of bacteria in infected tissues. Appl Microbiol. 1972 Mar;23(3):509–514. doi: 10.1128/am.23.3.509-514.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Simonetti N., Strippoli V. Pathogenicity of the Y form as compared to M form in experimentally induced Candida albicans infections. Mycopathol Mycol Appl. 1973 Sep 28;51(1):19–28. doi: 10.1007/BF02141282. [DOI] [PubMed] [Google Scholar]
  35. TASCHDJIAN C. L., BURCHALL J. J., KOZINN P. J. Rapid identification of Candida albicans by filamentation on serum and serum substitutes. AMA J Dis Child. 1960 Feb;99:212–215. doi: 10.1001/archpedi.1960.02070030214011. [DOI] [PubMed] [Google Scholar]
  36. Winblad B. Experimental renal candidiasis in mice and guinea pigs. Acta Pathol Microbiol Scand A. 1975 Jul;83(4):406–414. doi: 10.1111/j.1699-0463.1975.tb01890.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES